Ambulatory visits for opioid use disorders rose six-fold between 2001-2003 and 2007-2009 (P=0.004), but treatment with pharmacotherapy rose at a similar rate (P<0.001), Joseph Frank, MD, of Brigham & Women’s Hospital, and colleagues wrote in a research letter in the Archives of Internal Medicine. That increase was driven largely by greater use of buprenorphine (Subutex, Suboxone) to treat opioid addiction, they wrote.
Visits for opioid abuse rose six-fold, from 772,000 to 4.4 million. In the beginning of that time period, opioid abuse accounted for 7% of all substance use disorder visits, but by the end of the study period, it accounted for a quarter (P=0.004).
Source: MedPageToday.com – October 22, 2012